Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 349.01M | 330.48M | 271.82M | 232.34M | 191.91M | 151.53M |
Gross Profit | 263.03M | 247.96M | 194.37M | 167.22M | 139.25M | 111.24M |
EBITDA | 19.25M | 12.55M | -10.66M | -30.12M | -52.25M | -14.38M |
Net Income | -23.93M | -29.09M | -21.73M | -41.63M | -35.22M | -17.00M |
Balance Sheet | ||||||
Total Assets | 598.85M | 519.05M | 442.58M | 415.53M | 388.74M | 169.05M |
Cash, Cash Equivalents and Short-Term Investments | 351.80M | 290.90M | 226.88M | 229.81M | 270.63M | 70.10M |
Total Debt | 11.65M | 16.53M | 14.72M | 16.74M | 0.00 | 0.00 |
Total Liabilities | 237.40M | 248.11M | 217.74M | 172.38M | 133.17M | 148.87M |
Stockholders Equity | 359.50M | 270.95M | 210.60M | 229.15M | 250.35M | 17.13M |
Cash Flow | ||||||
Free Cash Flow | 99.87M | 85.85M | 31.17M | -6.24M | 2.57M | 18.10M |
Operating Cash Flow | 105.88M | 88.89M | 34.69M | -774.00K | 5.03M | 19.12M |
Investing Cash Flow | -16.49M | -2.60M | -5.65M | -21.45M | -3.38M | 1.37M |
Financing Cash Flow | 73.61M | -15.54M | -33.67M | -17.15M | 198.62M | 35.56M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
65 Neutral | $3.84B | ― | -8.39% | ― | 21.70% | -67.95% | |
64 Neutral | $2.63B | 26.98 | -41.63% | ― | 13.21% | 109.61% | |
64 Neutral | $4.35B | 8.73 | -8.85% | ― | -14.03% | -167.03% | |
64 Neutral | $1.94B | ― | -3.09% | ― | -1.96% | 19.43% | |
63 Neutral | $33.76B | 6.14 | -11.84% | 1.84% | 5.29% | -18.23% | |
63 Neutral | $3.78B | ― | -0.71% | ― | 34.37% | 95.80% |
On June 9, 2025, AvePoint, Inc. announced the redemption of all its outstanding public warrants to purchase shares of its common stock, originally issued under a 2019 Warrant Agreement. The redemption is set for July 9, 2025, at a price of $0.01 per warrant, with unexercised warrants becoming void post-redemption. This move reflects AvePoint’s strategic decision to streamline its equity structure, potentially impacting warrant holders who must decide whether to exercise their warrants at $11.50 per share before the deadline.
The most recent analyst rating on (AVPT) stock is a Hold with a $7.50 price target. To see the full list of analyst forecasts on AvePoint stock, see the AVPT Stock Forecast page.